We've updated our Privacy Policy to make it clearer how we use your personal data.

We use cookies to provide you with a better experience. You can read our Cookie Policy here.

Advertisement
Simulations Plus Releases Software Update for Pharmaceutical Drug Design
Product News

Simulations Plus Releases Software Update for Pharmaceutical Drug Design

Simulations Plus Releases Software Update for Pharmaceutical Drug Design
Product News

Simulations Plus Releases Software Update for Pharmaceutical Drug Design


Want a FREE PDF version of This Product News?

Complete the form below and we will email you a PDF version of "Simulations Plus Releases Software Update for Pharmaceutical Drug Design"

First Name*
Last Name*
Email Address*
Country*
Company Type*
Job Function*
Would you like to receive further email communication from Technology Networks?

Technology Networks Ltd. needs the contact information you provide to us to contact you about our products and services. You may unsubscribe from these communications at any time. For information on how to unsubscribe, as well as our privacy practices and commitment to protecting your privacy, check out our Privacy Policy

Simulations Plus, Inc. has announced that it has released Version 4.5 of its ClassPharmer software for analysis of chemical libraries and design of new molecular structures.

Dr. David Miller, team leader for Discovery Informatics for Simulations Plus, said: “This update to ClassPharmer incorporates several significant improvements to further enhance the pharmaceutical research chemist’s ability to design new drug molecules faster and with greater insight than ever before.”

Dr. Miller continued: “Pharmaceutical chemists have an extremely difficult task – finding a molecule in a potential set of perhaps a trillion, trillion, trillion, trillion, trillion (1060) small organic molecules that is able to satisfy hundreds of different criteria. Tools that can rapidly generate new molecular structures with desired characteristics, and that can assist the chemist to understand how changes to the structure of a molecule affect its many different qualities, are changing how discovery science is working.”

“In the drug discovery phase of chemistry, chemists work with large numbers of molecular structures. Some of them have been synthesized and tested against a therapeutic target. Some are only virtual molecules – they exist only in a structure drawing in a computer.”

ClassPharmer helps chemists to see relationships between the real structures and their measured properties, and to use those relationships to create and modify virtual molecules to identify the best ones for the next iteration of synthesis and tests. ClassPharmer 4.5 provides tight integration with our ADMET Predictor™ software, so that with ClassPharmer’s new methods for generating new molecules, the chemist can also use the predictive models in ADMET Predictor to assess whether the molecules are likely to have desirable properties,” Dr. Miller said.

Advertisement